SLC2A1 and neoplasm: Among the data from four tumor types with SLC2A1 phosphorylation information included in CPTAC, we found a decreased S490 phosphorylation in BRCA, increased T234 phosphorylation in HNSC, and increased T234 phosphorylation in KIRC (Figures 5B–D).